NEW YORK (GenomeWeb News) – Celera reported after the close of the market on Wednesday that its third-quarter revenues fell 13 percent, while its net loss rose 6 percent year over year.

The Alameda, Calif.-based molecular diagnostics firm generated revenues of $40 million for the three-month period ended Sept. 26, down from revenues of $45.8 million for the comparable period a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.